Search Results 951-960 of 17146 for Antagonist
One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...
Levels will be checked at baseline and also at day +4 post intervention. Patients taking H2-antagonists or proton pump inhibitors; Patients on therapeutic ...
Vitamin K antagonists; i.e. warfarin, acenocoumarol etc.;; Criterion not applicable for participants on therapy with direct-acting oral anticoagulants (DOACs) ...
About this study. The primary objective of this study is to determine the safety and tolerability of utilizing the insulin-like growth factor-1-methotrexate ...
About this study. The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Patients must have a one-week washout period from prior hormonal therapy (e.g., testosterone, estrogen, progestin, gonadotropin-releasing hormone antagonist).
Other enteropathies will also be included: collagenous sprue, idiopathic sprue, lymphocytic enterocolitis, idiopathic enteropathies, collagenous gastritis, ...
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!